ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Possible Government Shutdown Looms Over Biomedical Research Funding Once More

September 23, 2011

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009